ASCO AI Study Develops Machine Learning Models for Multicancer Risk Stratification Using Routine Clinical Data
Rapid Read

ASCO AI Study Develops Machine Learning Models for Multicancer Risk Stratification Using Routine Clinical Data

What's Happening? An international study presented at the ESMO Congress 2026 by ASCO AI has developed and validated approximately 500 machine learning models designed to stratify risk for the 20 most common cancer types. These models utilize routinely collected clinical data, including demographic i
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.